Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts

Is Methylprednisolone recalled?

Yes — there is an active recall. 5 ongoing FDA recalls mention Methylprednisolone (93 total). Check the affected lots below.

Most common reason: Sterility / contamination (39 of these recalls)

Recalls are matched by product description. A recall usually affects specific lots, not every package of Methylprednisolone. “Active” means an FDA recall is still ongoing; “closed” means it was terminated or completed. Checked against openFDA on Oct 10, 2026.

Methylprednisolone recalls in 2026

1 initiated in 2026, 93 in total — newest first
Class II · Moderate risk

methylprednisolone tablets

Labeling: Not Elsewhere Classified. Incorrect orientation of the blister foil applied to the blister cavities, which results in incorrect dosing information when following the directions on the foil.

Ongoing Labeling / mix-up Greenstone Llc NDC 59762-4440-2 D-0299-2026
Class III · Low risk

Methylprednisolone Acetate Injectable Suspension

Labeling: Not Elsewhere Classified; A typographical error was observed in the NDC number on the preprinted Individual Folding Cartons (secondary packaging only). Incorrect NDC Number 70121-1573-1; Correct NDC Number 70121-1574-1.

Terminated Labeling / mix-up Amneal Pharmaceuticals of New York, LLC NDC 70121-1574-01 D-0756-2023
Class II · Moderate risk

Depo-Medrol

cGMP deviations: Temperature abuse

Terminated Temperature excursion Mckesson Medical-Surgical Inc. Corporate Office NDC 0009-3475-01 D-1097-2022
Class II · Moderate risk

Depo-Medrol

cGMP deviations: Temperature abuse

Terminated Temperature excursion Mckesson Medical-Surgical Inc. Corporate Office NDC 0009-3073-03 D-1096-2022
Class III · Low risk

Distributed by: DocRx

Labeling: Illegible label: Manufacturer received complaint of mis-alignment print of the printed dosing instructions on the blister card.

Ongoing Labeling / mix-up Asclemed USA Inc. dba Enovachem Pharmaceuticals D-0330-2021
Class III · Low risk

Methylprednisolone Tablets USP

Labeling: Illegible label: Customer complaint received of mis-alignment print of the printed dosing instructions on the blister card.

Terminated Labeling / mix-up Jubilant Cadista Pharmaceuticals, Inc. NDC 59746-001-03 D-0298-2021